☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
marketing
NightWare Receives the US FDA's Approval for the First Medical Device to Stop NightMAres Related to PTSD
November 11, 2020
Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar
October 5, 2020
Sun Pharma Reports Submission of Manufacturing and Marketing Authorization Application of Tildrakizumab in Japan
August 1, 2019
Sanofi Reports Results of Cablivi (caplacizumab) in P-III HERCULES Study in Patients with Rare Blood Clotting Disorder- Published...
January 10, 2019
Pharmacosmos' Monoferric 1000 mg IV Receives Health Canada Marketing Approval
September 7, 2018
Celltrion's Herzuma (Herceptin biosimilar) Receives Marketing Approval in Australia
August 3, 2018
AbbVie Receives EC’s Conditional Marketing for Tepkinly (Epcoritamab) to R/R Follicular Lymphoma (FL)
August 22, 2024
How Innovative Public Relation Solutions Shape the Biopharma Industry?
August 6, 2024
Pfizer Reports the EC’s Conditional Approval of Durveqtix (Fidanacogene Elaparvovec) for the Treatment of Hemophilia B
July 26, 2024
Ono Pharmaceutical Reports the EMA’s Acceptance of MAA for Vimseltinib to Treat Tenosynovial Giant Cell Tumor (TGCT)
July 19, 2024
Redefining Technology: Xochitl Javier from Thermo Fisher Scientific in Conversation with PharmaShots
July 8, 2024
Johnson & Johnson’s Sirturo Gains the US FDA & EC’s Approval to Treat Pulmonary Tuberculosis
July 3, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.